Regeneron, the US biotech firm that supplied synthetic antibodies to treat President Donald Trump’s Covid-19, announced Wednesday it had more positive results to show from an ongoing clinical trial. The company had previously announced results for 275 people in its late-stage study of non-hospitalized Covid-19 patients on REGN-COV2, and said data from an additional 524 […]
